CareTrust REIT Prices 19.55 Million-Share Forward Offering at $36 Per Share

CareTrust REIT (CTRE) priced a 19.55 million share offering at $36 per share, raising about $703.8 million. The deal includes 17 million shares and 2.55 million additional shares after underwriters exercised options. Bank of America and Morgan Stanley are involved in forward sale agreements, with settlement possible until November 12, 2027.

Original reporting
Published Nov 13, 2026, 10:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 10:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CareTrust REIT Prices 19.55 Million-Share Forward Offering at $36 Per Share — source image
Decision brief

The 30-second read

$CTREBearishHigh
01

Why it matters

The forward offering provides significant capital but introduces dilution, likely prompting short‑term sell‑offs.

02

Market read

Primary disclosure of a large capital raise; immediate relevance for CTRE shareholders and REIT sector participants.

03

What to watch

Potential strategic use of proceeds for acquisitions or debt reduction may mitigate dilution concerns.

Relevance 9/10Novelty 9/10Timing: immediate reaction today

Background

CareTrust REIT is a publicly traded real‑estate investment trust focused on senior housing and healthcare properties.

Company-level read

Ticker impact

$CTREBearishHigh confidence
Context

CareTrust REIT announced a $703.8 million forward offering of 19.55 million shares at $36 each.

Expected impact

likely downward pressure as the market prices in dilution

Evidence & confidence

A multi‑hundred‑million capital raise is material and new; traders may sell on dilution risk.

Market effects

Adds supply pressure to the REIT sector, may prompt peers to reassess valuations.

US REIT market could see slight dip as investors weigh dilution risk.

Limited to REIT investors; no broad market effect.

Counterpoint

The cash infusion could fund growth projects, supporting a longer‑term upside.

Key entities

  • CareTrust REIT

    Issuer of the forward offering.

  • Bank of America

    Participating in the forward sale agreement.

  • Morgan Stanley

    Participating in the forward sale agreement.

Related articles

$CTREHighAI 9/10

CareTrust Announces Pricing of $638M Public Offering

CareTrust REIT Inc. priced a 17 million share offering, expected to raise $638M. Underwriters have a 30-day option for 2.55M more shares. The offering is set to close Nov. 13, led by BofA Securities, Morgan Stanley, J.P. Morgan, and Wells Fargo. Shares (CTRE) were down 1.8% to $37.89, with a market cap of $9.7B.

$CTREHigh

CareTrust REIT launches 17 million share public offering

CareTrust REIT (CTRE) announced a public offering of 17 million shares, with underwriters having a 30-day option to purchase an additional 2.55 million shares. The offering is structured through forward sale agreements with Bank of America, Morgan Stanley, J.P. Morgan, and Wells Fargo. Proceeds will be used for general corporate purposes, including acquisitions or debt repayment. The company operates healthcare-related properties in the U.S. and U.K.

$CTREMed

Raymond James cuts CareTrust REIT stock price target on yield outlook

Raymond James reduced its price target on CareTrust REIT (CTRE) to $41 from $42, citing a yield outlook, while maintaining an Outperform rating. The firm noted CTRE's expansion and growth prospects, with $2.9B in investments year-to-date and a 4% dividend yield. CTRE's Q3 2026 earnings missed estimates, but revenue exceeded forecasts, showing a 35.6% increase. The company has a market cap of $10B and 44% revenue growth over the last twelve months.